Worldwide Practice Patterns in Lynch Syndrome Diagnosis and Management, Based on Data From the International Mismatch Repair Consortium

[1]  M. Dwyer,et al.  Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[2]  H. Hampel.  Genetic counseling and cascade genetic testing in Lynch syndrome , 2016, Familial Cancer.

[3]  Swati G. Patel,et al.  Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project , 2016, The American Journal of Gastroenterology.

[4]  E. Kuipers,et al.  Genetic testing for Lynch syndrome: family communication and motivation , 2015, Familial Cancer.

[5]  A. Barkun,et al.  American Gastroenterological Association Technical Review on the Diagnosis and Management of Lynch Syndrome. , 2015, Gastroenterology.

[6]  Alan Barkun,et al.  American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Lynch Syndrome. , 2015, Gastroenterology.

[7]  Randall W Burt,et al.  ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes , 2015, The American Journal of Gastroenterology.

[8]  Randall W Burt,et al.  Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. , 2014, Gastroenterology.

[9]  U. Ladabaum,et al.  Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  J. Mathers,et al.  Chemoprevention in Lynch syndrome , 2013, Familial Cancer.

[11]  E. Smets,et al.  Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists , 2013, Familial Cancer.

[12]  J. Mecklin,et al.  Colorectal surveillance in Lynch syndrome families , 2013, Familial Cancer.

[13]  C. Amos,et al.  Changes in screening behaviors and attitudes toward screening from pre‐test genetic counseling to post‐disclosure in Lynch syndrome families , 2013, Clinical genetics.

[14]  P. Møller,et al.  Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts , 2013, Gut.

[15]  Aung Ko Win,et al.  Substantial unexplained variation in cancer risks for MLH1 and MSH2 mutation carriers , 2012, Human mutation.

[16]  J. Potter,et al.  Identification of Lynch syndrome among patients with colorectal cancer. , 2012, JAMA.

[17]  E. Kuipers,et al.  Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤ 70 years. , 2012, Gynecologic oncology.

[18]  Gianni Tognoni,et al.  Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials , 2012, The Lancet.

[19]  J. Weitzel,et al.  Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  E. Kuipers,et al.  Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome , 2012, The Journal of pathology.

[21]  Aung Ko Win,et al.  Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Rodney J Scott,et al.  Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial , 2011, The Lancet.

[23]  A. Duval,et al.  Screening for Lynch Syndrome in Colorectal Cancer: Are We Doing Enough? , 2012, Annals of Surgical Oncology.

[24]  C. Boland,et al.  Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer , 2011, Annals of Internal Medicine.

[25]  Ewout W Steyerberg,et al.  The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. , 2011, Gastroenterology.

[26]  A. Algra,et al.  Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials , 2010, The Lancet.

[27]  S. Gruber,et al.  Prevalence and Predictors of Appropriate Colorectal Cancer Surveillance in Lynch Syndrome , 2010, The American Journal of Gastroenterology.

[28]  E. Dekker,et al.  One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. , 2010, Gastroenterology.

[29]  B. Bunting,et al.  Family communication, genetic testing and colonoscopy screening in hereditary non‐polyposis colon cancer: a qualitative study , 2009, Psycho-oncology.

[30]  Jeffrey R. Botkin,et al.  Summary of Recommendations: The Evaluation of Genomic Applications , 2022 .

[31]  Heather Hampel,et al.  Feasibility of screening for Lynch syndrome among patients with colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  F. Radvanyi,et al.  Identification in Daily Practice of Patients With Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer): Revised Bethesda Guidelines-Based Approach Versus Molecular Screening , 2008, The American Journal of Gastroenterology.

[33]  S. Gruber,et al.  Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[34]  Esa Läärä,et al.  Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome. , 2007, Gastroenterology.

[35]  S. Gallinger,et al.  Should healthcare providers have a duty to warn family members of individuals with an HNPCC-causing mutation? A survey of patients from the Ontario Familial Colon Cancer Registry , 2007, Journal of Medical Genetics.

[36]  P. Rothwell,et al.  Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies , 2007, The Lancet.

[37]  G. Parmigiani,et al.  Whole pelvic helical tomotherapy for locally advanced cervical cancer: technical implementation of IMRT with helical tomothearapy , 2009, Radiation oncology.

[38]  W. Frankel,et al.  Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. , 2006, Cancer research.

[39]  C. Gross,et al.  Screening Colonoscopy Use Among Individuals at Higher Colorectal Cancer Risk , 2006, Journal of clinical gastroenterology.

[40]  M. Munsell,et al.  Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. , 2006, The New England journal of medicine.

[41]  L. Koehly,et al.  Hereditary nonpolyposis colorectal cancer family members' perceptions about the duty to inform and health professionals' role in disseminating genetic information. , 2005, Genetic testing.

[42]  N. Aaronson,et al.  Screening behavior of individuals at high risk for colorectal cancer. , 2005, Gastroenterology.

[43]  A. de la Chapelle.  The Incidence of Lynch Syndrome , 2005, Familial Cancer.

[44]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[45]  F. Giardiello,et al.  Genetic testing and counselling for hereditary colorectal cancer , 2002 .

[46]  F. Giardiello,et al.  Review article: genetic testing and counselling for hereditary colorectal cancer. , 2002, Alimentary pharmacology & therapeutics.

[47]  G. Petersen,et al.  AGA technical review on hereditary colorectal cancer and genetic testing. , 2001, Gastroenterology.

[48]  J. Garber,et al.  Disclosure of familial genetic information: perceptions of the duty to inform. , 2000, The American journal of medicine.

[49]  L. Aaltonen,et al.  Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. , 2000, Gastroenterology.

[50]  H T Lynch,et al.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.

[51]  J. Mecklin,et al.  The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) , 1991, Diseases of the colon and rectum.